Samsung Bioepis’s Ontruzant (biosimilar, trastuzumab) Receives the Health Canada Approval for the Treatment of Breast & Gastric Ca...
February 2, 2022
Eli Lilly's Verzenio (abemaciclib) Receives the US FDA's Approval for People with HR+ HER2- High Risk Early Breast Cancer
October 13, 2021
PharmaShots Interview: Q BioMed's Denis Corin Shares Insights on the Agreement to Serve US Department of Defense and Veterans Affa...
July 13, 2021
PharmaShots Interview: Daiichi Sankyo's Ken Keller Shares Insights on NICE Recommendation for Enhertu in HER2 Positive Breast Canc...
June 2, 2021
Zydus Cadila Launches Ujvira (biosimilar- trastuzumab emtansine) for Early and Advanced HER2 Positive Breast Cancer
May 24, 2021
Boehringer Ingelheim to Acquires NBE-Therapeutics ~ $1.5B
December 11, 2020
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.